Rallybio Corp Sustainability Reports
Rallybio Corp. is a clinical-stage biotechnology company focused on identifying, acquiring, developing, and commercializing life-altering therapies for patients with severe and rare diseases. The company's pipeline mainly addresses clinical programs in complement dysregulation and hematology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
4 reports from 2021 to 2025